INLET STRATEGIES

Lobbying for COHERUS BIOSCIENCES, INC · pharmaceutical development

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $60,000.00 income · posted Apr 19, 2026

Lobbying activity 2

Health Issues

Issues related to domestic manufacturing of pharmaceuticals Federal financial support for the American Biotech Industry

Medicare/Medicaid

Federal Financial Support for the American Biotech Industry

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.